COMP <GO>

TELO vs QUCY // FORWARD P/E MULTIPLE

Telomir Pharmaceuticals Inc. (NASDAQ) VS. Quantum Cyber N.V. (NASDAQ) • 15-METRIC TALLY: TELO 2 — QUCY 1

■ METRIC PARITY

LAST: $0.91 (-0.56%) • MKT CAP: $67.4M

forward-pe

—

LAST: $0.72 (-4.67%) • MKT CAP: $66.2M

forward-pe

—

15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TELO VS. QUCY) EMERALD CELL = QUANTITATIVE EDGE

INSTITUTIONAL METRIC	TELO	QUCY	SPREAD (A - B)	ADVANTAGE	DEDICATED URL
Gross Profit Margin	—	72.60%	—	TIE	/gross-margins <GO>
Return on Invested Capital (ROIC)	-35.00%	-35.00%	0.00	TIE	/roic <GO>
EV/EBITDA & P/E Valuation	—	—	—	TIE	/valuation <GO>
Free Cash Flow Yield	-5.19%	-13.84%	+8.65	TELO	/fcf-yield <GO>
Operating Margin	—	-60.00%	—	TIE	/operating-margins <GO>
Net Profit Margin	—	-60.00%	—	TIE	/net-margins <GO>
Revenue Growth (YoY)	—	-39.90%	—	TIE	/revenue-growth <GO>
Dividend Yield & FCF Payout Safety	0.00%	0.00%	0.00	TIE	/dividend-safety <GO>
Altman Z-Score & Debt/Equity	—	—	—	TIE	/balance-sheet <GO>
Piotroski F-Score Quality	3/9	3/9	0.00	TIE	/piotroski-score <GO>
Options Implied Move & Put/Call Skew	—	—	—	TIE	/options-implied-move <GO>
RSI-14 & 200D SMA Momentum	27.4	30.6	-3.20	QUCY	/rsi-technicals <GO>
10Y Yield & FRED Macro Beta	—	—	—	TIE	/macro-sensitivity <GO>
Forward P/E Multiple ACTIVE	—	—	—	TIE	/forward-pe <GO>
Enterprise Scale & Market Cap	$67.4M	$66.2M	$1.2M	TELO	/market-cap <GO>

5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY

FISCAL YEAR	TELO REV	QUCY REV	TELO GROSS %	QUCY GROSS %	TELO FCF	QUCY FCF
FY 2025	$3.1M	$537.1K	—	72.6%	-$3.7M	-$11.0M
FY 2024	$556.1K	$894.0K	—	64.3%	-$5.1M	-$17.4M
FY 2023	$58.8M	—	—	—	-$3.9M	—

FRED MACRO REGIME CORRELATION COMPARISON PEARSON r

TELO // BETA —

QUCY // BETA —